Table 2.
The fraction of MRSA-positive individuals at each time point
| Baseline | 3 months | 6 months | 9 months | 12 months | |
|---|---|---|---|---|---|
| Placebo | 33/33 (100%) | 22/32 (69%) | 23/33 (70%) | 17/33 (52%) | 21/33 (64%) |
| Vitamin D | 32/32 (100%) | 20/29 (69%) | 18/28 (64%) | 16/24 (67%) | 13/25 (52%) |
| p value | 1.00 | 1.00 | 0.79 | 0.24 | 0.43 |
The figures designate numbers of individuals being positive for MRSA, divided per total number of individuals with available information. The percentage is written out in parenthesis